Oramed to Present at H.C. Wainwright Global Life Sciences Conference
NEW YORK, April 3, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming H.C. Wainwright Global Life Sciences Conference, taking place April 8-9, 2019 in London. Dr. Mark Hasleton, Vice President for […]
